Insulin aspart, recombinant Subcutaneous and Skyrizi topical
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Skyrizi topical and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Skyrizi
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Sleep Aid
- Insulin aspart, recombinant Subcutaneous-Sleep Aid Tablets
- Insulin aspart, recombinant Subcutaneous-Sleepinal
- Insulin aspart, recombinant Subcutaneous-Slo-Niacin
- Insulin aspart, recombinant Subcutaneous-Slow Fe
- Insulin aspart, recombinant Subcutaneous-Slow Release Iron
- Skyrizi topical-Insulin degludec
- Skyrizi topical-Insulin Degludec (U-100) Prefilled Pens
- Skyrizi topical-Insulin Degludec (U-100) Vials
- Skyrizi topical-Insulin Degludec (U-200) Prefilled Pens
- Skyrizi topical-Insulin degludec and liraglutide
- Skyrizi topical-Insulin degludec and liraglutide Subcutaneous